CardioComm Solutions Issues Correction with Respect to Closing First Tranche of Financing
23 Janvier 2014 - 1:00AM
Access Wire
TORONTO, ONTARIO - CardioComm Solutions,
Inc. (TSX VENTURE:EKG) ("CardioComm
Solutions" or the "Company") today issued the following correction
to its press release dated January 21, 2014 respecting the closing
of the first tranche of its ongoing private placement equity
financing: Please note that in the first tranche the Company
issued 1,622,222
units at a price of $0.0675 per unit, for
gross proceeds of $109,500.
About CardioComm
Solutions
CardioComm Solutions'
patented and proprietary technology is used in products for
recording, viewing, analyzing and storing electrocardiograms (ECGs)
for diagnosis and management of cardiac patients. Products are sold
worldwide through a combination of an external distribution network
and a North American-based sales team. The Company has earned the
ISO 13485 certification, is HPB approved, HIPAA compliant, and has
received FDA market clearance for its software devices. CardioComm
Solutions is headquartered in Toronto, Ontario, Canada, with
offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE
CONTACT:
Etienne Grima, Chief Executive
Officer
1-877-977-9425
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
CardioComm Solutions (TSXV:EKG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
CardioComm Solutions (TSXV:EKG)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024